Table 4.

Clinically significant change from pre- to post-tDCS administration in systolic^a and diastolic blood pressure^a and heart rate^b.

	Subject #2	Subject #3c	Subject #4	Subject #5	Subject #6	Subject #7d	Subject #9	Subject #10	Total
No. of days of systolic BP increase	2	2	0	1	0	0	1	0	6
No. of days of systolic BP decrease	3	2	2	1	4	4	2	1	19
No. of days of diastolic BP increase	1	0	2	0	1	0	0	1	5
No. of days of diastolic BP decrease	1	1	3	0	3	0	1	1	10
No. of days of heart rate increase	0	0	3	0	2	0	4	0	9
No. of days of heart rate decrease	2	2	1	1	1	3	1	3	14

^aA change of 10 mmHg is considered clinically significant.

^bA change of 10% is considered clinically significant.

^cData on systolic and diastolic blood pressure and heart rate were missing on Day 3.

^dData on systolic and diastolic blood pressure and heart rate were not collected on Days 9 and 10 as the subject did not come for the two study visits.